Endocrine system | |||||
---|---|---|---|---|---|
Endocrine system / Adrenocortical function testing | |||||
tetracosactide | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Synacthen (Atnahs Pharma UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Suspension for injection | |||||
Synacthen Depot (Atnahs Pharma UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Assessment of pituitary function | |||||
gonadorelin | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Gonadotrophin replacement therapy | |||||
choriogonadotropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Ovitrelle (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
follitropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Bemfola (Gedeon Richter (UK) Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Gonal-f (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Ovaleap (Theramex HQ UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Gonal-f (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
lutropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Luveris (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Growth hormone disorders | |||||
pegvisomant | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Somavert (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
somatropin | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA64 |
|||
Omnitrope Biosimilar for Growth hormone replacement therapy in adults
Omnitrope will be available as an option for GH in suitable patients who can not use Genotropin. The current Shared Care Agreement has expired. This should be updated and presented to the NEL FPG Shared Care working group within the next 6 months. |
|||||
Solution for injection | |||||
Norditropin FlexPro (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Norditropin NordiFlex (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
NutropinAq (Ipsen Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Omnitrope (Sandoz Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Omnitrope SurePal (Sandoz Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Saizen (Merck Serono Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Powder and solvent for solution for injection | |||||
Humatrope (Eli Lilly and Company Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Zomacton (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Acromegaly | |||||
octreotide | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Octreotide (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Sandostatin (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for suspension for injection | |||||
Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Diabetes mellitus | |||||
acarbose | FORMULARY PRODUCT | ||||
alogliptin | FORMULARY PRODUCT | ||||
biphasic insulin aspart | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Suspension for injection | |||||
NovoMix 30 FlexPen (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
NovoMix 30 Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
biphasic insulin lispro | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Suspension for injection | |||||
Humalog Mix25 (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Humalog Mix25 KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Humalog Mix50 (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Humalog Mix50 KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
biphasic isophane insulin | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Suspension for injection | |||||
Humulin M3 (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Humulin M3 KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Hypurin Porcine 30/70 Mix (Wockhardt UK Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
canagliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA390 NICE TA315 |
|||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
dapagliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA288 NICE TA390 NICE TA418 NICE TA679 NICE TA902 NICE TA775 |
|||
Use in Type 1 DIabetes and Heart Failure
Dapagliflozin is HOSPITAL INITIATION when prescribed for used in following indications:
Type 1 Diabetes - manufacturer has withdrawn license for use in Type 1 diabetes and subsequently NICE TA 597 has been withdawn.
Treatment of symptomatic chronic heart failure with reduced ejection fraction: following initiation by specialist and reveiw from hospital, and can be prescribed in primary care. The indication is in line with NICE TA 679
|
|||||
dulaglutide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Trulicity (Eli Lilly and Company Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
empagliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA390 NICE TA336 NICE TA773 NICE TA929 NICE TA942 |
|||
ertugliflozin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA572 NICE TA583 |
|||
WEL Diabetes guidelines
Guidelines for Type 2 Diabetes in WEL are availalbe on the Practice Portal (please click here). Please note Ertugliflozin is not on the current WEL guidelines. |
|||||
exenatide | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
Solution for injection | |||||
Byetta (AstraZeneca UK Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
gliclazide | FORMULARY PRODUCT | ||||
Modified-release tablet | |||||
Gliclazide (Non-proprietary) | FORMULARY PRODUCT | ||||
Diamicron MR (Servier Laboratories Ltd) | NON-FORMULARY | ||||
Edicil MR (Teva UK Ltd) | NON-FORMULARY | ||||
Ziclaseg (Lupin Healthcare (UK) Ltd) | NON-FORMULARY | ||||
glimepiride | FORMULARY PRODUCT | ||||
glipizide | NON-FORMULARY | ||||
insulin | FORMULARY PRODUCT |
NICE TA151 NICE TA943 |
|||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Insulin (Non-proprietary) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Actrapid (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Humulin S (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Hypurin Porcine Neutral (Wockhardt UK Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
insulin aspart | FORMULARY PRODUCT |
NICE TA151 |
|||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Fiasp (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Fiasp FlexTouch (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Fiasp Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
NovoRapid (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
NovoRapid FlexPen (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
NovoRapid FlexTouch (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
NovoRapid Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
NovoRapid PumpCart (Novo Nordisk Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
insulin degludec | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Tresiba FlexTouch (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Tresiba Penfill (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
insulin detemir | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Levemir FlexPen (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Levemir Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
insulin glargine | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Abasaglar (Eli Lilly and Company Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Abasaglar KwikPen (Eli Lilly and Company Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Lantus (Sanofi) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
insulin glulisine | FORMULARY PRODUCT |
NICE TA151 |
|||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Apidra (Sanofi) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Apidra SoloStar (Sanofi) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
insulin lispro | FORMULARY PRODUCT |
NICE TA151 |
|||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Solution for injection | |||||
Humalog (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Humalog KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
isophane insulin | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Suspension for injection | |||||
Humulin I (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Humulin I KwikPen (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Hypurin Porcine Isophane (Wockhardt UK Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Insulatard (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Insulatard InnoLet (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
Insulatard Penfill (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Insulin advice
All INSULINS should be prescribed by BRAND, strength and formulation
SPECIALIST INITIATION for Type 1 and 2 diabetes in peadiatrics: can be prescribed in primary after initiation from specialist.
|
|||||
linagliptin | FORMULARY PRODUCT | ||||
liraglutide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA664 |
|||
Solution for injection | |||||
Saxenda (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Victoza (Novo Nordisk Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
lixisenatide | NON-FORMULARY | ||||
Solution for injection | |||||
Lyxumia (Sanofi) | NON-FORMULARY | ||||
metformin hydrochloride | FORMULARY PRODUCT | ||||
Modified-release tablet | |||||
Metformin hydrochloride (Non-proprietary) | FORMULARY PRODUCT | ||||
Glucient SR (Consilient Health Ltd) | NON-FORMULARY | ||||
Glucophage SR (Merck Serono Ltd) | NON-FORMULARY | ||||
Meijumet (Medreich Plc) | NON-FORMULARY | ||||
Metabet SR (Morningside Healthcare Ltd) | NON-FORMULARY | ||||
Sukkarto SR (Morningside Healthcare Ltd) | NON-FORMULARY | ||||
Sukkarto is formulary
Sukkarto product is formulary |
|||||
Oral solution | |||||
Metformin hydrochloride (Non-proprietary) | FORMULARY PRODUCT | ||||
pioglitazone | FORMULARY PRODUCT | ||||
repaglinide | FORMULARY PRODUCT | ||||
saxagliptin | NON-FORMULARY | ||||
semaglutide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA875 |
|||
HOSPITAL INITIATION AND THEN PRESCRIBING IN PRIMARY CARE - SUB-CUT INJ
HOSPITAL INITIATION ONLY AND PRIMARY CARE CONTINUATION - SEMAGLUTIDE SUB-CUT INJECTION Ensure initiation by hospital. Can be prescribed in primary care without shared care guideline. |
|||||
sitagliptin | FORMULARY PRODUCT | ||||
sitagliptin with metformin | NON-FORMULARY | ||||
tolbutamide | FORMULARY PRODUCT | ||||
vildagliptin | FORMULARY PRODUCT | ||||
vildagliptin with metformin | NON-FORMULARY | ||||
Endocrine system / Diabetic nephropathy | |||||
irbesartan | FORMULARY PRODUCT | ||||
Endocrine system / Diabetic neuropathy | |||||
capsaicin | HOSPITAL ONLY PRESCRIBING | ||||
carbamazepine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Modified-release tablet | |||||
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Oral suspension | |||||
Carbamazepine (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Tegretol (Novartis Pharmaceuticals UK Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Suppository | |||||
Carbamazepine (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
duloxetine | FORMULARY PRODUCT | ||||
Gastro-resistant capsule | |||||
Duloxetine (Non-proprietary) | FORMULARY PRODUCT | ||||
Cymbalta (Eli Lilly and Company Ltd) | NON-FORMULARY | ||||
Yentreve (Eli Lilly and Company Ltd) | FORMULARY PRODUCT | ||||
Endocrine system / Hypoglycaemia | |||||
glucagon | FORMULARY PRODUCT | ||||
Powder and solvent for solution for injection | |||||
GlucaGen Hypokit (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Endocrine system / Chronic hypoglycaemia | |||||
diazoxide | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Corticosteroid responsive conditions | |||||
betamethasone | FORMULARY PRODUCT | ||||
Solution for injection | |||||
Betamethasone (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
deflazacort | NON-FORMULARY | ||||
dexamethasone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA229 NICE TA824 NICE TA460 |
|||
Oral solution | |||||
Dexamethasone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Solution for injection | |||||
Dexamethasone (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Palliative Care Injectables
According to the East London Health and Care Partnership HOSPITAL ONLY PRESCRIBING LIST this is UNSUITABLE for prescribing in Primary Care unless for Palliative care indication.
|
|||||
fludrocortisone acetate | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
hydrocortisone | FORMULARY PRODUCT | ||||
Solution for injection | |||||
Hydrocortisone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Powder for solution for injection | |||||
Solu-Cortef (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Solu-Cortef (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
methylprednisolone | NON-FORMULARY | ||||
Powder and solvent for solution for injection | |||||
Solu-Medrone (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Suspension for injection | |||||
Depo-Medrone (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
prednisolone | FORMULARY PRODUCT | ||||
Gastro-resistant tablet | |||||
Prednisolone (Non-proprietary) | FORMULARY PRODUCT | ||||
Dilacort (Crescent Pharma Ltd) | NON-FORMULARY | ||||
Oral solution | |||||
Prednisolone (Non-proprietary) | FORMULARY PRODUCT | ||||
Suppository | |||||
Prednisolone (Non-proprietary) | FORMULARY PRODUCT | ||||
triamcinolone acetonide | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Suspension for injection | |||||
Adcortyl Intra-articular / Intradermal (Bristol-Myers Squibb Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Kenalog (Bristol-Myers Squibb Pharmaceuticals Ltd) | NON-FORMULARY | ||||
Endocrine system / Cushing's syndrome and disease | |||||
metyrapone | HOSPITAL ONLY PRESCRIBING | ||||
pasireotide | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Signifor (Recordati Rare Diseases UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for suspension for injection | |||||
Signifor (Recordati Rare Diseases UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Female sex hormone responsive conditions | |||||
conjugated oestrogens with medroxyprogesterone | |||||
Modified-release tablet | |||||
Premique (Pfizer Ltd) | FORMULARY PRODUCT | ||||
estradiol | FORMULARY PRODUCT | ||||
Transdermal patch | |||||
Estraderm MX (Norgine Pharmaceuticals Ltd) | NON-FORMULARY | ||||
Estradot (Sandoz Ltd) | NON-FORMULARY | ||||
Evorel (Theramex HQ UK Ltd) | FORMULARY PRODUCT | ||||
FemSeven (Theramex HQ UK Ltd) | NON-FORMULARY | ||||
Progynova TS (Bayer Plc) | NON-FORMULARY | ||||
estradiol with dydrogesterone | |||||
Form unstated | |||||
Femoston 2/10 (Viatris UK Healthcare Ltd) | NON-FORMULARY | ||||
estradiol with levonorgestrel | |||||
Transdermal patch | |||||
FemSeven Conti (Theramex HQ UK Ltd) | NON-FORMULARY | ||||
estradiol with medroxyprogesterone | |||||
Form unstated | |||||
Tridestra (Orion Pharma (UK) Ltd) | NON-FORMULARY | ||||
estradiol with norethisterone | FORMULARY PRODUCT | ||||
Form unstated | |||||
Elleste Duet (Viatris UK Healthcare Ltd) | FORMULARY PRODUCT | ||||
Novofem (Novo Nordisk Ltd) | FORMULARY PRODUCT | ||||
Trisequens (Novo Nordisk Ltd) | NON-FORMULARY | ||||
ethinylestradiol | FORMULARY PRODUCT | ||||
medroxyprogesterone acetate | FORMULARY PRODUCT | ||||
norethisterone | FORMULARY PRODUCT | ||||
progesterone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Solution for injection | |||||
Progesterone (Non-proprietary) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Lubion (IBSA Pharma Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Vaginal gel | |||||
Crinone (Merck Serono Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
raloxifene hydrochloride | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA160 NICE TA161 |
|||
tibolone | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Endocrine system / Anti-oestrogens | |||||
clomifene citrate | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Male sex hormone antagonism | |||||
cyproterone acetate | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Endocrine system / Dopamine responsive conditions | |||||
bromocriptine | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
cabergoline | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
quinagolide | NON-FORMULARY | ||||
Form unstated | |||||
Quinagolide (Non-proprietary) | NON-FORMULARY | ||||
Endocrine system / Bone metabolism disorders | |||||
alendronic acid | FORMULARY PRODUCT |
NICE TA464 |
|||
Oral solution | |||||
Alendronic acid (Non-proprietary) | NON-FORMULARY | ||||
alendronic acid with colecalciferol | NON-FORMULARY | ||||
calcitonin (salmon) | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Calcitonin (salmon) (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
calcitriol | NON-FORMULARY | ||||
Oral solution | |||||
Calcitriol (Non-proprietary) | NON-FORMULARY | ||||
denosumab | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA204 NICE TA265 |
|||
A formal Shared Care Guideline (SCG) may be available.
Denosumab (Prolia) is Shared Care when used for the treatment of osteoporosis in post-menopausal women. All other indications for denosumab remain for Hospital Only Prescribing.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
DENOSUMAB
Shared Care Agreement available for Denosumab in post menopausal osteoporosis |
|||||
Hospital only indication
HOSPITAL ONLY for skeletal related events in cancer |
|||||
Solution for injection | |||||
Prolia (Amgen Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
Xgeva (Amgen Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
ibandronic acid | NON-FORMULARY |
NICE TA464 |
|||
IBANDRONIC ACID
PARENTERAL FORMULATION IS FOR HOSPITAL PRESCRIBING ONLY |
|||||
Solution for injection | |||||
Ibandronic acid (Non-proprietary) | NON-FORMULARY | ||||
Bonviva (Atnahs Pharma UK Ltd) | NON-FORMULARY | ||||
Solution for infusion | |||||
Ibandronic acid (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Bondronat (Atnahs Pharma UK Ltd) | NON-FORMULARY | ||||
pamidronate disodium | HOSPITAL ONLY PRESCRIBING | ||||
Solution for infusion | |||||
Pamidronate disodium (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
raloxifene hydrochloride | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines |
NICE TA160 NICE TA161 |
|||
risedronate sodium | FORMULARY PRODUCT |
NICE TA464 |
|||
risedronate with calcium carbonate and colecalciferol | NON-FORMULARY | ||||
sodium clodronate | HOSPITAL ONLY PRESCRIBING | ||||
teriparatide | HOSPITAL ONLY PRESCRIBING |
NICE TA161 |
|||
Solution for injection | |||||
Forsteo (Eli Lilly and Company Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
zoledronic acid | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines |
NICE TA464 |
|||
Infusion | |||||
Aclasta (Sandoz Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Zometa (Phoenix Labs Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
Solution for infusion | |||||
Zoledronic acid (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Zometa (Phoenix Labs Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Diabetes insipidus | |||||
chlortalidone | FORMULARY PRODUCT | ||||
desmopressin | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
Oral lyophilisate | |||||
DDAVP Melt (Ferring Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
DesmoMelt (Ferring Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with Shared Care Guidelines | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
Noqdirna (Ferring Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Solution for injection | |||||
DDAVP (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Octim (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Spray | |||||
Desmopressin (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Desmospray (Imported (Germany)) | NON-FORMULARY | ||||
A formal Shared Care Guideline (SCG) may be available.
If it is for the specific condition you are asked to continue treatment for and you are happy to prescribe in accordance with the guideline, then take over the agreed responsibilities including prescribing. Please ensure the document is scanned into the patient's electronic records. |
|||||
vasopressin | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Vasopressin (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Syndrome of inappropriate antidiuretic hormone secretion | |||||
tolvaptan | HOSPITAL ONLY PRESCRIBING |
NICE TA358 |
|||
Endocrine system / Thyroid disorders | |||||
thyrotropin alfa | HOSPITAL ONLY PRESCRIBING | ||||
Powder for solution for injection | |||||
Thyrogen (Sanofi) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Hyperthyroidism | |||||
carbimazole | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
iodide with iodine | HOSPITAL ONLY PRESCRIBING | ||||
metoprolol tartrate | FORMULARY PRODUCT | ||||
Solution for injection | |||||
Betaloc (Recordati Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
nadolol | NON-FORMULARY | ||||
propranolol hydrochloride | FORMULARY PRODUCT | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | NON-FORMULARY | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | NON-FORMULARY | ||||
Half Beta-Prograne (Accord-UK Ltd, Teva UK Ltd, Tillomed Laboratories Ltd) | NON-FORMULARY | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | FORMULARY PRODUCT | ||||
propylthiouracil | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Endocrine system / Hypothyroidism | |||||
levothyroxine sodium | FORMULARY PRODUCT | ||||
Oral solution | |||||
Levothyroxine sodium (Non-proprietary) | FORMULARY PRODUCT | ||||
liothyronine sodium | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
LIOTHYRONINE SODIUM
There is insufficient evidence of clinical & cost effectiveness to support the use of liothyronine (either alone or in combination) for the treatment of primary hypothyroidism.
|
|||||
Powder for solution for injection | |||||
Liothyronine sodium (Non-proprietary) | HOSPITAL ONLY PRESCRIBING | ||||
Endocrine system / Gonadotrophin responsive conditions | |||||
buserelin | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Suprecur (Neon Healthcare Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Suprefact (Neon Healthcare Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Spray | |||||
Suprecur (Neon Healthcare Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
cetrorelix | HOSPITAL ONLY PRESCRIBING | ||||
Powder and solvent for solution for injection | |||||
Cetrotide (Merck Serono Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
ganirelix | HOSPITAL ONLY PRESCRIBING | ||||
Solution for injection | |||||
Fyremadel (Ferring Pharmaceuticals Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
goserelin | HOSPITAL ONLY PRESCRIBING | ||||
HOSPITAL ONLY INDICATIONS
Goserelin - Hospital prescribing for all indications except for treatment of Prostate cancer |
|||||
leuprorelin acetate | HOSPITAL ONLY PRESCRIBING | ||||
HOSPITAL ONLY
Leuprorelin is HOSPITAL ONLY for all indications except for prostate cancer
|
|||||
Powder and solvent for suspension for injection | |||||
Prostap 3 DCS (Takeda UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Prostap SR DCS (Takeda UK Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
nafarelin | HOSPITAL ONLY PRESCRIBING | ||||
Spray | |||||
Synarel (Pfizer Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
relugolix with estradiol and norethisterone acetate | HOSPITAL ONLY PRESCRIBING |
NICE TA832 |
|||
Relugolix-estradiol-norethisterone acetate (Ryeqo) for Moderate to severe symptoms of uterine fibroids (TA832)
Hospital only (Red) - status to be reviewed to Amber (Transfer of care) once transfer of care information agreed with specialist teams. |
|||||
triptorelin | HOSPITAL ONLY PRESCRIBING | ||||
Precocious Puberty
Please be aware that there is no shared care for the management of Precocious puberty in TNW |
|||||
Powder and solvent for suspension for injection | |||||
Decapeptyl SR (Ipsen Ltd) | HOSPITAL ONLY PRESCRIBING | ||||
Gonapeptyl Depot (Ferring Pharmaceuticals Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Salvacyl (Ipsen Ltd) | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
Endocrine system / Breast pain (mastalgia) | |||||
tamoxifen | SPECIALIST INITIATED- Primary care to continue with no Shared Care Guidelines | ||||
SPECIALIST INITIATION - TAMOXIFEN
Please note, Specialist initiation refers to when initiated by hospital specialist or can be initiated from primary care on recommendation of specialist |
|||||
Oral solution | |||||
Tamoxifen (Non-proprietary) | NON-FORMULARY |